| abstract |
The present invention relates to a compound of general formula and pharmaceutically acceptable salts, hydrates or solvates thereof, wherein R is (C 1 -C 7 ) alkyl, (C 2 -C 7 ) alkenyl or (C 2 -C 7 ) Alkynyl; wherein R is substituted by R1; used alone or in combination with one or more other pharmaceutically active compounds for therapy, for the prevention, treatment or amelioration of burst oxidative responses to stimulated neutrophils, to stimulated Diseases or conditions in which keratinocyte IL-8 release is in response or in response to induction of necrosis. |